Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Clinical trial NCT01997411 · COMPLETED

Trial details

NCT number: NCT01997411
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2013-11-01
Primary completion: 2015-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.